Addition of histamine to IL-2 treatment augments T1 cell-function in melanoma patients <it>in vivo</it>: results from a randomized clinical trial of IL-2 with or without histamine (MP 104)

• Gehlsen K,
• Thiel E,
• Hellstrand K,
• Letsch A,
• Scheibenbogen C,
• Asemissen AM,
• Keilholz U

Affiliations

Gehlsen K

Thiel E

Hellstrand K

Letsch A

Scheibenbogen C

Asemissen AM

Keilholz U